Greg D. Aunan - May 1, 2024 Form 4 Insider Report for NEOGENOMICS INC (NEO)

Role
Chief Accounting Officer
Signature
/s/ Ali Olivo, Attorney-in-Fact
Stock symbol
NEO
Transactions as of
May 1, 2024
Transactions value $
$0
Form type
4
Date filed
5/3/2024, 04:07 PM
Previous filing
May 24, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NEO Common Stock Tax liability $0 -937 -6.09% $0.00 14.5K May 1, 2024 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction NEO Stock Option (Right to Buy) Award $0 +27K $0.00 27K May 2, 2024 Common Stock 27K $13.96 Direct F3
transaction NEO Restricted Stock Unit Award $0 +16.1K $0.00 16.1K May 2, 2024 Common Stock 16.1K $0.00 Direct F4, F5
holding NEO Stock Option (Right to Buy) 28.7K May 1, 2024 Common Stock 28.7K $14.62 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares surrendered to NeoGenomics Inc. for retirement to satisfy the tax obligations in connection with the May 1, 2024 vesting of restricted stock.
F2 On May 1, 2023, Mr. Aunan was granted 28,662 stock options. These options vest ratably over the first four anniversary dates of the grant date.
F3 On May 2, 2024, Mr. Aunan was granted 26,978 stock options. These options vest ratably over the first three anniversary dates of the grant date.
F4 On May 2, 2024, Mr. Aunan was granted 16,117 restricted stock units. These restricted stock units vest ratably over the first three anniversary dates of the grant date.
F5 Once vested, the shares of common stock are not subject to expiration.